Mohamed Abdelmoaty Elbadawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohamed Abdelmoaty Elbadawy has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Mohamed Aboelnaga
Department of surgery, fuculty of medicine, suez canal university
1 shared publication Amr A Gomaa
Plastic and Reconstructive Surgery Unit, Department of Surgery, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
1 shared publicationAmr Abdallah Gomaa
Plastic surgery department, faculty of medicine, Suez Canal University
1 shared publication- Amr M. Moghazy
Plastic Surgery and Burns, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
1 shared publication Kai Liu
1 shared publicationMoaz Fathy Abbady
Health insurance hospital, Suez
1 shared publication
Latest Publications
- 27 May 2024
- Published by Elsevier in Computers and Geotechnics
- Vol. 172
An improved pressure dependent multi-yield surface model: calibration and validation
- 27 May 2024
- Published by Elsevier in Computers and Geotechnics
- Vol. 172
An improved pressure dependent multi-yield surface model: calibration and validation
- Open Access
- 12 December 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Comparison between Intralesional Injection of Botulinum Toxin A and Triamcinolone in Management of Recent Hypertrophic Scars
Background: Hypertrophic scars lead to aesthetic and local symptoms . Moreover these scars have psychological effects such as embarrassment and low self-confidence. Many treatment modalities had been used, but each one has its limited effect. Objectives: The aim of the study is toevaluate the role of hypertrophic scars management by comparing intralesional injection of Botulinum Toxin (BTX-A) to intralesional injection of triamcinolone . Subjects and methods: This study was carried on 20 patients with hypertrophic scars, their scars were divided into two equal sectors, one sector was injected with BTX-A while the other sector was injected with corticosteroid (triamcinolone) as a control. Assessment of the results were achieved objectively and digitally photographed using the same camera, lightening setting and patient positioning before treatment, at one-month, three months and six months' visits. The hypertrophic scar score was calculated before and after treatment by patient and observer scar assessment scale (POSAS). Results: There was statistically significant improvement in both BTX-A and triamcinolone injected scars. The different parameters that assessed by POSAS showed better improvement and significant lower scores in the BTX-A injected areas without side effects. The triamcinolone injected scars showed complication such as atrophy, hypopigmentations. The results of the study revealed that BTX-A has a significant role in treatment of hypertrophic scars with minimal side effects. Conclusion: In conclusion, intralesional injection of BTX-A is suitable for treatment of recent hypertrophic scars with decreasing associated pain and itching and better tolerated than corticosteroid.
- 12 December 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Open AccessComparison between Intralesional Injection of Botulinum Toxin A and Triamcinolone in Management of Recent Hypertrophic Scars
Background: Hypertrophic scars lead to aesthetic and local symptoms . Moreover these scars have psychological effects such as embarrassment and low self-confidence. Many treatment modalities had been used, but each one has its limited effect. Objectives: The aim of the study is toevaluate the role of hypertrophic scars management by comparing intralesional injection of Botulinum Toxin (BTX-A) to intralesional injection of triamcinolone . Subjects and methods: This study was carried on 20 patients with hypertrophic scars, their scars were divided into two equal sectors, one sector was injected with BTX-A while the other sector was injected with corticosteroid (triamcinolone) as a control. Assessment of the results were achieved objectively and digitally photographed using the same camera, lightening setting and patient positioning before treatment, at one-month, three months and six months' visits. The hypertrophic scar score was calculated before and after treatment by patient and observer scar assessment scale (POSAS). Results: There was statistically significant improvement in both BTX-A and triamcinolone injected scars. The different parameters that assessed by POSAS showed better improvement and significant lower scores in the BTX-A injected areas without side effects. The triamcinolone injected scars showed complication such as atrophy, hypopigmentations. The results of the study revealed that BTX-A has a significant role in treatment of hypertrophic scars with minimal side effects. Conclusion: In conclusion, intralesional injection of BTX-A is suitable for treatment of recent hypertrophic scars with decreasing associated pain and itching and better tolerated than corticosteroid.
- 8 January 2022
- Published by Elsevier in Soil Dynamics and Earthquake Engineering
- Vol. 154
A modified pressure dependent multi-yield surface model for simulation of LEAP-Asia-2019 centrifuge experiments
- 8 January 2022
- Published by Elsevier in Soil Dynamics and Earthquake Engineering
- Vol. 154
A modified pressure dependent multi-yield surface model for simulation of LEAP-Asia-2019 centrifuge experiments
- 4 February 2021
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 46 (8) , 857-864
Aesthetic and functional outcomes of thinned anterolateral thigh flap in reconstruction of complex wounds of the upper limb
We studied outcomes of reconstruction of complex upper limb wounds using thinned anterolateral thigh flaps. There were 18 patients with a mean age of 27.5 years. The mean thickness of the flap before and after thinning was 23 mm and 5 mm, respectively. Two patients had partial tip necrosis that was treated conservatively. Aesthetic and functional evaluations were performed using a 5-point Likert scale, QuickDASH score, passive range of motion and power grip at 12 months after surgery. The study showed good results in the aesthetic evaluation by a panel of plastic surgeons (mean score: 19.7) and patient self-assessment (mean score: 18.1). There was a significant correlation between the total scores of the panel and the patients. The mean QuickDASH score was 21, with a high percentage in the middle category ‘had a problem but working’. The thinned anterolateral thigh flap is versatile and safe in upper limb reconstruction with good aesthetic and functional results. Level of evidence: IV
- 4 February 2021
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 46 (8) , 857-864
Aesthetic and functional outcomes of thinned anterolateral thigh flap in reconstruction of complex wounds of the upper limb
We studied outcomes of reconstruction of complex upper limb wounds using thinned anterolateral thigh flaps. There were 18 patients with a mean age of 27.5 years. The mean thickness of the flap before and after thinning was 23 mm and 5 mm, respectively. Two patients had partial tip necrosis that was treated conservatively. Aesthetic and functional evaluations were performed using a 5-point Likert scale, QuickDASH score, passive range of motion and power grip at 12 months after surgery. The study showed good results in the aesthetic evaluation by a panel of plastic surgeons (mean score: 19.7) and patient self-assessment (mean score: 18.1). There was a significant correlation between the total scores of the panel and the patients. The mean QuickDASH score was 21, with a high percentage in the middle category ‘had a problem but working’. The thinned anterolateral thigh flap is versatile and safe in upper limb reconstruction with good aesthetic and functional results. Level of evidence: IV